title: The complete genome and phenome of a community-acquired Acinetobacter baumannii.
abstract: Many sequenced strains of Acinetobacter baumannii are established nosocomial pathogens capable of resistance to multiple antimicrobials. Community-acquired A. baumannii in contrast, comprise a minor proportion of all A. baumannii infections and are highly susceptible to antimicrobial treatment. However, these infections also present acute clinical manifestations associated with high reported rates of mortality. We report the complete 3.70 Mbp genome of A. baumannii D1279779, previously isolated from the bacteraemic infection of an Indigenous Australian; this strain represents the first community-acquired A. baumannii to be sequenced. Comparative analysis of currently published A. baumannii genomes identified twenty-four accessory gene clusters present in D1279779. These accessory elements were predicted to encode a range of functions including polysaccharide biosynthesis, type I DNA restriction-modification, and the metabolism of novel carbonaceous and nitrogenous compounds. Conversely, twenty genomic regions present in previously sequenced A. baumannii strains were absent in D1279779, including gene clusters involved in the catabolism of 4-hydroxybenzoate and glucarate, and the A. baumannii antibiotic resistance island, known to bestow resistance to multiple antimicrobials in nosocomial strains. Phenomic analysis utilising the Biolog Phenotype Microarray system indicated that A. baumannii D1279779 can utilise a broader range of carbon and nitrogen sources than international clone I and clone II nosocomial isolates. However, D1279779 was more sensitive to antimicrobial compounds, particularly beta-lactams, tetracyclines and sulphonamides. The combined genomic and phenomic analyses have provided insight into the features distinguishing A. baumannii isolated from community-acquired and nosocomial infections.
authors.affiliation: Department of Chemistry and Biomolecular Sciences, Macquarie University, Sydney, New South Wales, Australia.
authors.forename: Daniel N
authors.initials: DN
authors.lastname: Farrugia
authors.forename: Liam D H
authors.initials: LD
authors.lastname: Elbourne
authors.forename: Karl A
authors.initials: KA
authors.lastname: Hassan
authors.forename: Bart A
authors.initials: BA
authors.lastname: Eijkelkamp
authors.forename: Sasha G
authors.initials: SG
authors.lastname: Tetu
authors.forename: Melissa H
authors.initials: MH
authors.lastname: Brown
authors.forename: Bhumika S
authors.initials: BS
authors.lastname: Shah
authors.forename: Anton Y
authors.initials: AY
authors.lastname: Peleg
authors.forename: Bridget C
authors.initials: BC
authors.lastname: Mabbutt
authors.forename: Ian T
authors.initials: IT
authors.lastname: Paulsen
mesh_terms: D000151:Acinetobacter Infections / Q000188:drug therapy / Q000382:microbiology*; D040981:Acinetobacter baumannii / Q000187:drug effects / Q000235:genetics* / Q000302:isolation & purification; D002874:Chromosome Mapping; D017714:Community-Acquired Infections / Q000188:drug therapy / Q000382:microbiology; D004251:DNA Transposable Elements / Q000235:genetics; D004269:DNA, Bacterial / Q000235:genetics; D024881:Drug Resistance, Bacterial / Q000235:genetics; D016680:Genome, Bacterial; D006801:Humans; D005810:Multigene Family; D020411:Oligonucleotide Array Sequence Analysis; D011706:Pyloric Antrum
chemical_list: D004251:DNA Transposable Elements; D004269:DNA, Bacterial